These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36466382)

  • 21. Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS).
    Shutov E; Sułowicz W; Esposito C; Tataradze A; Andric B; Reusch M; Valluri U; Dimkovic N
    Nephrol Dial Transplant; 2021 Aug; 36(9):1629-1639. PubMed ID: 33630072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of Daprodustat Vs rhEPO for Anemia in Patients With Chronic Kidney Disease: A Meta-Analysis and Trial Sequential Analysis.
    Fu Z; Geng X; Chi K; Song C; Wu D; Liu C; Hong Q
    Front Pharmacol; 2022; 13():746265. PubMed ID: 35359863
    [No Abstract]   [Full Text] [Related]  

  • 23. Roxadustat for the treatment of anemia in patients with chronic kidney diseases: a meta-analysis.
    Zhang L; Hou J; Li J; Su SS; Xue S
    Aging (Albany NY); 2021 Jun; 13(13):17914-17929. PubMed ID: 34115611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and safety of roxadustat in the treatment of anemia of kidney disease: a systematic review and meta-analysis.
    Wang H; Huang K; Wang C; Chen C; Fang H; Cao J
    Ann Palliat Med; 2021 Apr; 10(4):4736-4746. PubMed ID: 33966423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular and renal safety outcomes of hypoxia-inducible factor prolyl-hydroxylase inhibitor roxadustat for anemia patients with chronic kidney disease: a systematic review and meta-analysis.
    Tian L; Wang M; Liu M; Pang Y; Zhao J; Zheng B; Wang Y; Zhao W
    Ren Fail; 2024 Dec; 46(1):2313864. PubMed ID: 38345037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of roxadustat on anemia, iron metabolism, and lipid metabolism in patients with non-dialysis chronic kidney disease.
    Hirai K; Kaneko S; Minato S; Yanai K; Hirata M; Kitano T; Ito K; Ueda Y; Ookawara S; Morishita Y
    Front Med (Lausanne); 2023; 10():1071342. PubMed ID: 36910473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effectiveness and acceptability of HIF prolyl-hydroxylase inhibitors
    Huang Q; You M; Huang W; Chen J; Zeng Q; Jiang L; Du X; Liu X; Hong M; Wang J
    Front Pharmacol; 2023; 14():1050412. PubMed ID: 37521459
    [No Abstract]   [Full Text] [Related]  

  • 28. Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES).
    Barratt J; Andric B; Tataradze A; Schömig M; Reusch M; Valluri U; Mariat C
    Nephrol Dial Transplant; 2021 Aug; 36(9):1616-1628. PubMed ID: 34077510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron Parameters in Patients Treated with Roxadustat for Anemia of Chronic Kidney Disease.
    Ganz T; Locatelli F; Arici M; Akizawa T; Reusch M
    J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445252
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roxadustat and Oral Iron Absorption in Chinese Patients with Anemia of Chronic Kidney Disease: A Randomized, Open-Label, Phase 4 Study (ALTAI).
    Wu H; Cheng H; Wang C; Yao L; Qin S; Zuo L; Hu Z; Zhang C; Wu Y; Hofherr A; Mohan K; Rush S; Li X
    Adv Ther; 2024 Mar; 41(3):1168-1183. PubMed ID: 38280066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical parameters among patients in Japan with anemia and non-dialysis-dependent chronic kidney disease with and without diabetes mellitus who received roxadustat.
    Akizawa T; Tanaka-Amino K; Otsuka T; Yamaguchi Y
    Clin Exp Nephrol; 2022 Sep; 26(9):843-850. PubMed ID: 35462610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roxadustat treatment for anemia in peritoneal dialysis patients: A randomized controlled trial.
    Hou YP; Mao XY; Wang C; Xu ZH; Bu ZH; Xu M; Li B
    J Formos Med Assoc; 2022 Feb; 121(2):529-538. PubMed ID: 34167878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase 3 Study of Roxadustat to Treat Anemia in Non-Dialysis-Dependant CKD.
    Akizawa T; Iwasaki M; Otsuka T; Yamaguchi Y; Reusch M
    Kidney Int Rep; 2021 Jul; 6(7):1810-1828. PubMed ID: 34307976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) on anemia in non-dialysis-dependent chronic kidney disease (NDD-CKD): a systematic review and meta-analysis.
    Zhang S; Guo J; Xie S; Chen J; Yu S; Yu Y
    Int Urol Nephrol; 2021 Jun; 53(6):1139-1147. PubMed ID: 33026571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and Effectiveness of Roxadustat in Dialysis-Dependent Patients With Renal Anemia: A Hospital-Based Cohort Study.
    Moussa O; Feng C; Wang JX; Li XS; Zhang FX; Tang XH
    Cureus; 2022 Apr; 14(4):e24427. PubMed ID: 35475244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and Safety of Daprodustat for Anemia Therapy in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis.
    Zheng Q; Wang Y; Yang H; Sun L; Fu X; Wei R; Liu YN; Liu WJ
    Front Pharmacol; 2020; 11():573645. PubMed ID: 33597868
    [No Abstract]   [Full Text] [Related]  

  • 37. Roxadustat (FG-4592) Versus Epoetin Alfa for Anemia in Patients Receiving Maintenance Hemodialysis: A Phase 2, Randomized, 6- to 19-Week, Open-Label, Active-Comparator, Dose-Ranging, Safety and Exploratory Efficacy Study.
    Provenzano R; Besarab A; Wright S; Dua S; Zeig S; Nguyen P; Poole L; Saikali KG; Saha G; Hemmerich S; Szczech L; Yu KH; Neff TB
    Am J Kidney Dis; 2016 Jun; 67(6):912-24. PubMed ID: 26846333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of roxadustat on iron metabolism in patients with peritoneal dialysis: a real-world 24-week study.
    Zhang X; Jia R; Zheng Z; Jiang L; Xu Y; Raj A; Sun D
    Eur J Med Res; 2023 Nov; 28(1):489. PubMed ID: 37936193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Roxadustat in Chinese Hemodialysis Patients: A Systematic Review and Meta-Analysis.
    Liang Q; Li X; Niu Q; Zhao H; Zuo L
    J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.
    Chen N; Hao C; Liu BC; Lin H; Wang C; Xing C; Liang X; Jiang G; Liu Z; Li X; Zuo L; Luo L; Wang J; Zhao MH; Liu Z; Cai GY; Hao L; Leong R; Wang C; Liu C; Neff T; Szczech L; Yu KP
    N Engl J Med; 2019 Sep; 381(11):1011-1022. PubMed ID: 31340116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.